Chih-Ming Chiang
Research Subjects
Research Interests
Chih-Ming Chiang has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Kuan-Hung Lin
Department of Horticulture and Biotechnology, Chinese Culture University, Taipei 111, Taiwan
1 shared publication - Shao-Wei Huang1 shared publication
- Shwu-Fen Pan1 shared publication
- Yi-Hung Li
Department of Biotechnology and Animal Science, National Ilan University, No. 1, Sec. 1, Shennong Rd., Yilan City 26047, Taiwan
1 shared publication
Latest Publications
- Open Access
- 26 June 2026
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Pharmacology
- Vol. 21 (2) , 72-83
Effects of ethanolic leaf extract of Gynura divaricata on NF-κB pathway in human HeLa cells
This study aims to evaluate the anti-cancer activity of the ethanolic leaf extract of Gynura divaricata in human cervical cancer HeLa cells. Cells were treated with various concentrations of extract, and cell viability was assessed to determine the half-maximal inhibitory concentration (IC50). The extract significantly reduced HeLa cell viability in a concentration-dependent manner, demonstrating marked cytotoxic activity. Treatment with 2x IC50 extract markedly suppressed cellular metabolic activity and significantly downregulated the expression of NF-κB-related genes compared with control and DMSO-treated cells. The extract also reduced the transcription of inflammatory and apoptosis-associated factors, including TNF-α, Bcl-2, Bax, COX-2, IKKα, IκBα, IL-8, IL-6, and IL-1β. These findings indicate that G. divaricata inhibits HeLa cell growth by suppressing NF-κB-mediated signaling and inflammatory responses, suggesting its potential as a natural therapeutic agent against cervical cancer.
- 26 June 2026
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Pharmacology
- Vol. 21 (2) , 72-83
Open AccessEffects of ethanolic leaf extract of Gynura divaricata on NF-κB pathway in human HeLa cells
This study aims to evaluate the anti-cancer activity of the ethanolic leaf extract of Gynura divaricata in human cervical cancer HeLa cells. Cells were treated with various concentrations of extract, and cell viability was assessed to determine the half-maximal inhibitory concentration (IC50). The extract significantly reduced HeLa cell viability in a concentration-dependent manner, demonstrating marked cytotoxic activity. Treatment with 2x IC50 extract markedly suppressed cellular metabolic activity and significantly downregulated the expression of NF-κB-related genes compared with control and DMSO-treated cells. The extract also reduced the transcription of inflammatory and apoptosis-associated factors, including TNF-α, Bcl-2, Bax, COX-2, IKKα, IκBα, IL-8, IL-6, and IL-1β. These findings indicate that G. divaricata inhibits HeLa cell growth by suppressing NF-κB-mediated signaling and inflammatory responses, suggesting its potential as a natural therapeutic agent against cervical cancer.